Format

Send to

Choose Destination
See comment in PubMed Commons below
Inflammopharmacology. 2011 Oct;19(5):243-4. doi: 10.1007/s10787-011-0089-1. Epub 2011 Aug 30.

A note on the evaluation of BoNTA trial quality.

Abstract

In their systematic review, Zhang et al. evaluate randomized controlled trials on the efficacy of Botulinum toxin type A (BoNTA) in helping patients with musculoskeletal disorders. Scoring each trial according to the Jadad scale they note that the studies range from 1 to 5 with an average of 4.1, which they interpret as a testimony of the high quality of the studies included. Unfortunately, we cannot share the author's enthusiasm, as a perfect Jadad score of 5 is no guarantee that a study is of good quality.

PMID:
21877123
DOI:
10.1007/s10787-011-0089-1
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center